EXALT SD7 CLINICAL CASE STUDIES

ERIC J. LULLOVE, DPM, CWS, FACCWSBOCA RATON, FL

Exsalt™ SD7 Wound Dressing

Description The exsaltTM SD7 wound dressing provides an antimicrobial barrier that inhibits microbial growth in the dressing. The exsalt™ SD7 wound dressing consists of three layers: two non-adherent polyethylene mesh wound contact layers and one absorbent core made of polyester. All three layers are silver coated. The concentration of silver on the exsalt™ SD7 wound dressing is approximately 0.4 mg/cm2 (2.5% w/w).

Indications The exsaltTM SD7 wound dressing is indicated for the management of partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and grafted wounds.

74 year old female presents with chronic non-healing ulcer of her right leg. Area was clotted and necrotic pre-debridement.

Post-debridement patient developed local contamination of the ulcer site, and Exalt SD7 was used to reduce bacterial load.

Exalt was used to complete wound closure.

Case 1:

Case 1

Case 1

Case 1

Complete Healing at 7 weeks

52 year old diabetic male admitted to local hospital for gas gangrene of the left foot.

Patient underwent partial 1st ray resection and delayed primary closure.

Exalt SD7 used post-operatively in management of heavy exudate with significant malodor.

Clinically, patient improved after 1 week and remarkable healing after 1 month.

Case 2:

Case 2

Case 2

Note the amountOf silver absorbed by the wound bed with the dressing able to withstand one week application without dressing change

Case 2

Case 2

Patient is slowly progressing to healing, but has not needed additional Exalt DS-7 since 10-8-10.

83 year old male with history of severe left lower extremity edema presented with chronic venous ulcers to left medial ankle.

Exalt DS-7 used to absorb exudate and provide a stable clean wound bed to the area to promote more granulation tissue and less aggressive bacterial dermatitis.

Case 3:

Case 3

Exalt DS-7 started 4-5-10 after positive culture for MRSA to wound bed

Case 3

Complete Healing NotedTwo weeks of Exalt DS-7 with eradication of MRSA infection and healing.

Exalt SD7 has shown in the preceding cases that it is a viable dressing alternative to other silver products as its nature of a 3+ valency allows for more aqueous silver to penetrate the wound bed. This technology allows for more rapid-onset reduction of bacterial load and therefore, increased healing rates.

Conclusions